MARKET

SPHRF

SPHRF

Starpharma Holdings Ltd
OTCMQB
0.350
NaN%
Opening 09:30 05/21 EDT
OPEN
--
PREV CLOSE
0.350
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.350
52 WEEK LOW
0.240
MARKET CAP
147.32M
P/E (TTM)
-68.6275
1D
5D
1M
3M
1Y
5Y
1D
Starpharma Wins FDA Backing for DEP HER2 Trial as Partnerships and Product Sales Advance
TipRanks · 04/29 00:48
Starpharma Secures FDA Backing for DEP HER2 First-in-Human Trial Pathway
TipRanks · 04/21 00:04
Starpharma plans first-in-human Phase 1 trial of DEP HER2 radiotherapy in Europe
PUBT · 04/20 23:43
Rhuroin becomes Starpharma substantial holder with 9.52% stake
PUBT · 04/14 22:46
Starpharma Seeks ASX Quotation for Over 1 Million New Shares
TipRanks · 04/06 23:33
UBS Group Ceases to Be Substantial Shareholder in Starpharma
TipRanks · 03/12 02:39
Starpharma Ramps Up DEP® Partnerships and Radiopharma Pipeline as Viraleze™ Sales Surge
TipRanks · 01/29 02:27
Starpharma Seeks ASX Quotation for 1.69 Million New Ordinary Shares
TipRanks · 01/07 02:18
More
About SPHRF
Starpharma Holdings Limited is an Australia-based biotechnology company specializing in advancing dendrimer technology. The Company's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The Company's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. It also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The Company has applied its DEP technology to the innovative area of antibody-drug conjugates.

Webull offers Starpharma Holdings Ltd stock information, including OTCMQB: SPHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPHRF stock methods without spending real money on the virtual paper trading platform.